Genetic disruption of NRF2 promotes the development of necroinflammation and liver fibrosis in a mouse model of HFE-hereditary hemochromatosis

Abstract

Background and AimsIn hereditary hemochromatosis, iron deposition in the liver parenchyma may lead to fibrosis, cirrhosis and hepatocellular carcinoma. Most cases are ascribed to a common mutation in the HFE gene, but the extent of clinical expression is greatly influenced by the combined action of yet unidentified genetic and/or environmental modifying factors. In mice, transcription factor NRF2 is a critical determinant of hepatocyte viability during exposure to acute dietary iron overload. We evaluated if the genetic disruption of Nrf2 would prompt the development of liver damage in Hfe-/- mice (an established model of human HFE-hemochromatosis).MethodsWild-type, Nrf2-/-, Hfe-/- and double knockout (Hfe/Nrf2-/-) female mice on C57BL/6 genetic background were sacrificed at the age of 6 (young), 12–18 (middle-aged) or 24 months (old) for evaluation of liver pathology.ResultsDespite the parenchymal iron accumulation, Hfe-/- mice presented no liver injury. The combination of iron overload (Hfe-/-) and defective antioxidant defences (Nrf2-/-) increased the number of iron-related necroinflammatory lesions (sideronecrosis), possibly due to the accumulation of toxic oxidation products such as 4-hydroxy-2-nonenal-protein adducts. The engulfment of dead hepatocytes led to a gradual accumulation of iron within macrophages, featuring large aggregates. Myofibroblasts recruited towards the injury areas produced substantial amounts of collagen fibers involving the liver parenchyma of double-knockout animals with increased hepatic fibrosis in an age-dependent manner.ConclusionsThe genetic disruption of Nrf2 promotes the transition from iron accumulation (siderosis) to liver injury in Hfe-/- mice, representing the first demonstration of spontaneous hepatic fibrosis in the long term in a mouse model of hereditary hemochromatosis displaying mildly elevated liver iron.

Rapamycin Induced Autophagy Inhibits Inflammation-Mediated Endplate Degeneration by Enhancing Nrf2/Keap1 Signaling of Cartilage Endplate Stem Cells

“…Under normal conditions, Nrf2 binds to Keap1 and keeps it in an inactive state. Nrf2/Keap1 is a novel therapeutic target for the treatment of age‐related diseases in heart , skeletal muscle , liver , and eye . Nrf2/Keap1 signaling dysfunction results in shortened life expectancy and premature senescence .…”

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

“…The observation that disruption of NRF2 in mice impeded liver regeneration following partial hepatectomy led to the discovery that NRF2 regulates the gene expression of Notch1 113 , a mechanism that is also involved in the NRF2-mediated improvement of hematopoietic stem progenitor cell function and myelosuppression following exposure to ionizing radiation 114 . In a mouse model of hereditary hemochromatosis with iron overload (due to mutation of the Homeostatic Iron Regulator gene), knockout of NRF2 increased necro-inflammatory lesions within livers of the knockout mice that led to hepatic fibrosis 115 . Consistent with these observations, patients with primary biliary cholangitis and cirrhosis exhibit reduced NRF2 expression 116 .…”

Anti‑apoptotic effects of human placental hydrolysate against hepatocyte toxicity in�vivo and in�vitro

“…In Nrf2-deficient mice, the expression of various cytopro-tective enzymes was decreased in hepatocytes, resulting in oxidative stress and markedly delayed liver regeneration ( 81 ). In addition, genetic disruption of Nrf2 triggers the progression of necroinflammation and hepatic fibrosis in Hfe -/- mice presenting with no liver injury ( 82 ). Pretreatment with sulforaphane prevents hepatic damage induced by intestinal ischemia/reperfusion in rats through an antioxidative effect via the Nrf2-ARE pathway ( 79 ).…”